Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Methamphetamine hydrochloride - Generic Drug Details

« Back to Dashboard
Methamphetamine hydrochloride is the generic ingredient in three branded drugs marketed by Able, Rexar, West-ward Pharms Int, Teva, Recordati Rare, and Mayne Pharma Inc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for methamphetamine hydrochloride. Four suppliers are listed for this compound.

Summary for Generic Name: methamphetamine hydrochloride

Drug Master File Entries: see list6
Suppliers / Packagers: see list4
Bulk Api Vendors: see list48
Clinical Trials: see list1,027
Patent Applications: see list5,208
Therapeutic Class:Central Nervous System Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:methamphetamine hydrochloride at DailyMed

Pharmacology for Ingredient: methamphetamine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma Inc
methamphetamine hydrochloride
TABLET;ORAL091189-001Apr 21, 2010RXNoNo► subscribe► subscribe
Recordati Rare
methamphetamine hydrochloride
TABLET, EXTENDED RELEASE;ORAL005378-005Approved Prior to Jan 1, 1982DISCNNoNo► subscribe► subscribe
Recordati Rare
methamphetamine hydrochloride
TABLET, EXTENDED RELEASE;ORAL005378-004Approved Prior to Jan 1, 1982DISCNNoNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.